share_log

12 Health Care Stocks Moving In Monday's Pre-Market Session

Benzinga ·  May 20 08:06

Gainers

  • GT Biopharma (NASDAQ:GTBP) stock rose 153.2% to $7.9 during Monday's pre-market session. The company's market cap stands at $10.9 million. As per the press release, Q1 earnings came out 3 days ago.
  • China Pharma Holdings, Inc. Common Stock (AMEX:CPHI) shares rose 42.9% to $0.47. As per the news, the Q1 earnings report came out 3 days ago.
  • Kintara Therapeutics (NASDAQ:KTRA) shares rose 28.95% to $0.18. The market value of their outstanding shares is at $7.1 million. The company's, Q3 earnings came out 4 days ago.
  • PTC Therapeutics (NASDAQ:PTCT) stock rose 26.9% to $42.0. The market value of their outstanding shares is at $3.2 billion.
  • China SXT Pharmaceuticals (NASDAQ:SXTC) stock increased by 25.21% to $1.44. The company's market cap stands at $1.3 million.
  • Cue Health (NASDAQ:HLTH) stock rose 24.48% to $0.12. The company's market cap stands at $19.0 million.

Losers

  • Virios Therapeutics (NASDAQ:VIRI) shares fell 44.1% to $0.2 during Monday's pre-market session. The company's market cap stands at $3.7 million.
  • Jaguar Health (NASDAQ:JAGX) shares fell 39.46% to $0.16. The market value of their outstanding shares is at $45.9 million. The company's, Q1 earnings came out 4 days ago.
  • Aesthetic Medical Intl (NASDAQ:AIH) shares fell 27.68% to $0.36. The company's market cap stands at $17.2 million.
  • Akanda (NASDAQ:AKAN) shares declined by 23.01% to $0.13. The company's market cap stands at $4.2 million.
  • Syra Health (NASDAQ:SYRA) shares decreased by 11.95% to $1.4. The market value of their outstanding shares is at $8.9 million.
  • Tenon Medical (NASDAQ:TNON) shares decreased by 9.58% to $0.77. The company's market cap stands at $2.8 million. As per the press release, Q1 earnings came out 4 days ago.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment